▶ 調査レポート

ワクチンアジュバントの世界市場2017

• 英文タイトル:Global Vaccine Adjuvants Market Research Report 2017

QYResearchが調査・発行した産業分析レポートです。ワクチンアジュバントの世界市場2017 / Global Vaccine Adjuvants Market Research Report 2017 / A04101075資料のイメージです。• レポートコード:A04101075
• 出版社/出版日:QYResearch / 2017年3月24日
• レポート形態:英文、PDF、144ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥304,500 (USD2,900)▷ お問い合わせ
  Enterprise¥609,000 (USD5,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ワクチンアジュバントの世界市場について調査・分析し、ワクチンアジュバントの世界市場概観、ワクチンアジュバントの種類別市場分析、用途別市場分析、ワクチンアジュバントの世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・ワクチンアジュバントの世界市場概観
・ワクチンアジュバントの種類別市場規模
・ワクチンアジュバントの用途別市場規模
・ワクチンアジュバントの世界市場規模
・ワクチンアジュバントの世界市場規模予測
・ワクチンアジュバントの主要地域別市場規模
・ワクチンアジュバントの北米市場規模・予測
・ワクチンアジュバントのヨーロッパ市場規模・予測
・ワクチンアジュバントの中国市場規模・予測
・ワクチンアジュバントの日本市場規模・予測
・ワクチンアジュバントのアジア市場規模・予測
・ワクチンアジュバントの製造メーカー分析
・ワクチンアジュバントのメーカー別生産量
・ワクチンアジュバントのメーカー別市場シェア
・ワクチンアジュバントの価格動向・価格分析
・ワクチンアジュバントの販売(売上高)動向
・ワクチンアジュバントの貿易(輸出・輸入)動向
・ワクチンアジュバントの産業チェーン分析
・ワクチンアジュバントのマーケティング戦略分析
・ワクチンアジュバントの販売業者(代理店)リスト
・ワクチンアジュバントの市場環境分析
...

The Global Vaccine Adjuvants Market Research Report 2017 is a professional and in-depth study on the current state of the Vaccine Adjuvants market. Annual estimates and forecasts are provided for the period 2017–2022. Also, a six-year historic analysis is provided for these markets. The global market for Vaccine Adjuvants is expected to reach about 920 M USD by 2022 from 560 M USD in 2017, registering a compounded annual growth rate (CAGR) of 10.3% during the analysis period, 2017-2022.
This report studies Vaccine Adjuvants in global market, especially in North America, Europe, Japan, Asia (Ex. Japan), etc. focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Veterinary Vaccine Adjuvants Manufacturers
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios

Human Vaccine Adjuvants Manufacturers
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Market segment by regions, this report splits global into several key regions, with production, consumption, revenue, and market share and growth rate of Vaccine Adjuvants in these regions, from 2011 to 2021 (forecast), like
North America
Europe
Japan
Asia (Ex. Japan)
Other

Split by product types, with production, revenue, price, and market share and growth rate of each type, can be divided into
Oral
Subcutaneous
Intramuscular
Others

Split application, this report focuses on consumption, market share and growth rate of Vaccine Adjuvants in each application, can be divided into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market

レポート目次

Table of Contents

1 Vaccine Adjuvants Market Overview 1
1.1 Product Overview and Scope of Vaccine Adjuvants 1
1.2 Vaccine Adjuvants Segment by Types 2
1.2.1 Global Production Market Share of Vaccine Adjuvants by Types in 2016 2
1.2.2 Oral 4
1.2.3 Subcutaneous 5
1.2.4 Intramuscular 6
1.2.5 Others 6
1.3 Vaccine Adjuvants Segment by Applications 7
1.3.1 Vaccine Adjuvants Consumption Market Share by Applications in 2016 7
1.3.2 Human Vaccine Adjuvants 8
1.3.3 Veterinary Vaccine Adjuvants 8
1.4 Vaccine Adjuvants Market by Regions 9
1.4.1 Veterinary Vaccine Adjuvants Market by Regions 9
1.4.1.1 North America Status and Prospect (2011-2022) 9
1.4.1.2 Europe Status and Prospect (2011-2022) 10
1.4.1.3 China Status and Prospect (2011-2022) 11
1.4.1.4 Asia (Ex. China) Status and Prospect (2011-2022) 12
1.4.2 Human Veterinary Vaccine Adjuvants Market by Regions 13
1.4.2.1 North America Status and Prospect (2011-2022) 13
1.4.2.2 Europe Status and Prospect (2011-2022) 14
1.4.2.3 China Status and Prospect (2011-2022) 15
1.4.2.4 Asia (Ex. China) Status and Prospect (2011-2022) 16
1.5 Global Market Size (Value) of Vaccine Adjuvants (2011-2022) 17
2 Veterinary Vaccine Adjuvants 19
2.1 Global Veterinary Vaccine Adjuvants Market Competition by Manufacturers 19
2.1.1 Global Veterinary Vaccine Adjuvants Production and Share by Manufacturers (2015 and 2016) 19
2.1.2 Global Veterinary Vaccine Adjuvants Revenue and Share by Manufacturers (2015 and 2016) 21
2.1.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2015 and 2016) 23
2.1.4 Manufacturers Veterinary Vaccine Adjuvants Headquarters and Sales Area 25
2.2 Global Veterinary Vaccine Adjuvants Production, Revenue (Value) by Regions (2011-2016) 26
2.2.1 Global Veterinary Vaccine Adjuvants Production and Market Share by Regions (2011-2016) 26
2.2.2 Global Veterinary Vaccine Adjuvants Revenue (Value) and Market Share by Regions (2011-2016) 27
2.3 Global Veterinary Vaccine Adjuvants Production, Revenue (Value), Price Trend by Types 29
2.3.1 Global Veterinary Vaccine Adjuvants Production and Market Share by Types (2011-2016) 29
2.3.2 Global Veterinary Vaccine Adjuvants Revenue and Market Share by Types (2011-2016) 31
2.3.3 Global Veterinary Vaccine Adjuvants Price by Type (2011-2016) 33
2.3.4 Global Veterinary Vaccine Adjuvants Production Growth by Type (2011-2016) 34
2.4 Global Veterinary Vaccine Adjuvants Market Analysis by Applications 34
2.4.1 Global Veterinary Vaccine Adjuvants Consumption and Market Share by Applications (2011-2016) 34
2.4.2 Global Veterinary Vaccine Adjuvants Consumption Growth Rate by Applications (2011-2016) 35
2.4.3 Market Drivers and Opportunities 36
2.5 Analysis of Veterinary Vaccine Adjuvants Industry Key Manufacturers 37
2.5.1 SEPPIC 37
2.5.1.1 Company Profile 37
2.5.1.2 Product Information 38
2.5.1.3 Production, Price, Cost, Gross, and Revenue 38
2.5.2 SDA BIO 39
2.5.2.1 Company Profile 39
2.5.2.2 Product Information 40
2.5.2.3 Production, Price, Cost, Gross, and Revenue 40
2.5.3 Brenntag Biosector 41
2.5.3.1 Company Profile 41
2.5.3.2 Product Information 42
2.5.3.3 Production, Price, Cost, Gross, and Revenue 42
2.5.4 SPI Pharma 43
2.5.4.1 Company Profile 43
2.5.4.2 Product Information 44
2.5.4.3 Production, Price, Cost, Gross, and Revenue 44
2.5.5 MVP Laboratories 45
2.5.5.1 Company Profile 45
2.5.5.2 Product Information 46
2.5.5.3 Production, Price, Cost, Gross, and Revenue 46
2.5.6 Tj Kaiwei 47
2.5.6.1 Company Profile 47
2.5.6.2 Product Information 48
2.5.6.3 Production, Price, Cost, Gross, and Revenue 48
2.5.7 Novavax 49
2.5.7.1 Company Profile 49
2.5.7.2 Product Information 50
2.5.7.3 Production, Price, Cost, Gross, and Revenue 50
2.5.8 Zhuoyue 51
2.5.8.1 Company Profile 51
2.5.8.2 Product Information 52
2.5.8.3 Production, Price, Cost, Gross, and Revenue 52
2.5.9 Aphios 53
2.5.9.1 Company Profile 53
2.5.9.2 Product Information 54
2.5.9.3 Production, Price, Cost, Gross, and Revenue 54
3 Human Vaccine Adjuvants 53
3.1 Global Human Vaccine Adjuvants Market Competition by Manufacturers 55
3.1.1 Global Human Vaccine Adjuvants Production and Share by Manufacturers (2015 and 2016) 55
3.1.2 Global Human Vaccine Adjuvants Revenue and Share by Manufacturers (2015 and 2016) 57
3.1.3 Global Human Vaccine Adjuvants Average Price by Manufacturers (2015 and 2016) 59
3.1.4 Manufacturers Human Vaccine Adjuvants Headquarters and Sales Area 60
3.2 Global Human Vaccine Adjuvants Production, Revenue (Value) by Regions (2011-2016) 60
3.3.1 Global Human Vaccine Adjuvants Production and Market Share by Regions (2011-2016) 60
3.3.2 Global Human Vaccine Adjuvants Revenue (Value) and Market Share by Regions (2011-2016) 62
3.3 Global Human Vaccine Adjuvants Production, Revenue (Value), Price Trend by Types 63
3.3.1 Global Human Vaccine Adjuvants Production and Market Share by Types (2011-2016) 63
3.3.2 Global Human Vaccine Adjuvants Revenue and Market Share by Types (2011-2016) 65
3.3.3 Global Human Vaccine Adjuvants Price by Type (2011-2016) 67
3.3.4 Global Human Vaccine Adjuvants Production Growth by Type (2011-2016) 67
3.4 Global Human Vaccine Adjuvants Market Analysis by Applications 68
3.4.1 Global Human Vaccine Adjuvants Consumption and Market Share by Applications (2011-2016) 68
3.4.2 Global Human Vaccine Adjuvants Consumption Growth Rate by Applications (2011-2016) 69
3.4.3 Market Drivers and Opportunities 70
3.5 Global Human Vaccine Adjuvants Manufacturers Profiles/Analysis 71
3.5.1 GSK 71
3.5.1.1 Company Profile 71
3.5.1.2 Product Information 72
3.5.1.3 Production, Price, Cost, Gross, and Revenue 72
3.5.2 CSL Limited 73
3.5.2.1 Company Profile 73
3.5.2.2 Product Information 74
3.5.2.3 Production, Price, Cost, Gross, and Revenue 74
3.5.3 Brenntag Biosector 75
3.5.3.1 Company Profile 75
3.5.3.2 Product Information 76
3.5.3.3 Production, Price, Cost, Gross, and Revenue 76
3.5.4 SEPPIC 77
3.5.4.1 Company Profile 77
3.5.4.2 Product Information 78
3.5.4.3 Production, Price, Cost, Gross, and Revenue 78
3.5.5 SPI Pharma 79
3.5.5.1 Company Profile 79
3.5.5.2 Product Information 80
3.5.5.3 Production, Price, Cost, Gross, and Revenue 80
3.5.6 Novavax 81
3.5.6.1 Company Profile 81
3.5.6.2 Product Information 82
3.5.6.3 Production, Price, Cost, Gross, and Revenue 82
3.5.7 Avanti Polar Lipids 83
3.5.7.1 Company Profile 83
3.5.7.2 Product Information 84
3.5.7.3 Production, Price, Cost, Gross, and Revenue 85
3.5.8 Aphios 85
3.5.8.1 Company Profile 85
3.5.8.2 Product Information 86
3.5.8.3 Production, Price, Cost, Gross, and Revenue 87
4 Vaccine Adjuvants Manufacturing Cost Analysis 88
4.1 Vaccine Adjuvants Key Raw Materials Analysis 88
4.1.1 Key Raw Materials 88
4.1.2 Key Suppliers of Raw Materials 88
4.2 Proportion of Manufacturing Cost Structure 90
4.2.1 Raw Materials 90
4.2.2 Labor Cost 90
4.2.2.1 USA Labor Cost Analysis 91
4.2.2.2 Europe Labor Costs Analysis 93
4.2.2.3 Asia Labor Costs Analysis 95
4.2.3 Other Costs Analysis 97
4.2.3.1 USA Other Cost Analysis 97
4.2.3.2 Europe Other Cost Analysis 99
4.2.3.3 China Other Cost Analysis 100
4.3 Manufacturing Process Analysis of Vaccine Adjuvants 102
5 Industrial Chain, Sourcing Strategy and Downstream Buyers 103
5.1 Vaccine Adjuvants Industrial Chain Analysis 103
5.2 Upstream Raw Materials Sourcing 104
5.3 Downstream Buyers 104
6 Marketing Strategy Analysis, Distributors/Traders 106
6.1 Marketing Channel 106
6.1.1 Direct Marketing 106
6.1.2 Indirect Marketing 106
6.1.3 Marketing Channel Development Trend 106
6.2 Market Positioning 106
6.2.1 Pricing Strategy 106
6.2.2 Brand Strategy 107
6.2.3 Target Client 107
6.3 Distributors/Traders List 107
7 Market Effect Factors Analysis 109
7.1 Technology Progress/Risk 109
7.1.1 Substitutes Threat 109
7.1.2 Technology Progress in Related Industry 109
7.2 Consumer Needs/Customer Preference Change 110
7.3 Economic/Political Environmental Change 111
8 Global Vaccine Adjuvants Market Forecast (2017-2022) 119
8.1 Global Veterinary Vaccine Adjuvants Market Forecast (2017-2022) 119
8.1.1 Global Veterinary Vaccine Adjuvants Production, Revenue Forecast (2017-2022) 119
8.1.2 Global Veterinary Vaccine Adjuvants Production, Consumption Forecast by Regions (2017-2022) 120
8.1.3 Global Veterinary Vaccine Adjuvants Production Forecast by Type (2017-2022) 121
8.1.4 Global Veterinary Vaccine Adjuvants Consumption Forecast by Application (2017-2022) 121
8.1.5 Veterinary Vaccine Adjuvants Price Forecast (2017-2022) 121
8.2 Global Human Vaccine Adjuvants Market Forecast (2017-2022) 122
8.2.1 Global Human Vaccine Adjuvants Production, Revenue Forecast (2017-2022) 122
8.2.2 Global Human Vaccine Adjuvants Production, Consumption Forecast by Regions (2017-2022) 123
8.2.3 Global Human Vaccine Adjuvants Production Forecast by Type (2017-2022) 124
8.2.4 Global Human Vaccine Adjuvants Consumption Forecast by Application (2017-2022) 124
8.2.5 Human Vaccine Adjuvants Price Forecast (2017-2022) 124
9 Research Findings and Conclusion 125
10 Appendix 127
Author List 127
Disclosure Section 128
Research Methodology 128
Data Source 129
Disclaimer 129

List of Tables and Figures

Figure Picture of Vaccine Adjuvants 1
Figure Global Production Market Share of Veterinary Vaccine Adjuvants by Route of Administration Types in 2016 2
Figure Global Production Market Share of Human Vaccine Adjuvants by Route of Administration Types in 2016 3
Table Classification of Vaccine Adjuvants 3
Figure Product Picture of Oral 4
Figure Product Picture of Subcutaneous 5
Figure Product Picture of Intramuscular 6
Figure Product Picture of Others 6
Table Vaccine Adjuvants Consumption Market Share by Applications in 2016 7
Table Applications of Vaccine Adjuvants 7
Figure Picture of Human Vaccine Adjuvants 8
Figure Picture of Veterinary Vaccine Adjuvants 8
Figure North America Veterinary Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 9
Figure Europe Veterinary Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 10
Figure China Veterinary Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 11
Figure Asia (Ex. China) Veterinary Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 12
Figure North America Human Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 13
Figure Europe Human Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 14
Figure China Human Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 15
Figure Asia (Ex. China) Human Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 16
Figure Global Veterinary Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 17
Figure Global Human Vaccine Adjuvants Revenue (M USD) and Growth Rate (2011-2022) 18
Table Global Veterinary Vaccine Adjuvants Production (MT) of Key Manufacturers (2015 and 2016) 19
Table Global Veterinary Vaccine Adjuvants Production Share by Manufacturers (2015 and 2016) 19
Figure 2015 Veterinary Vaccine Adjuvants Production Share by Manufacturers 20
Figure 2016 Veterinary Vaccine Adjuvants Production Share by Manufacturers 20
Table Global Veterinary Vaccine Adjuvants Revenue (M USD) by Manufacturers (2015 and 2016) 21
Table Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers (2015 and 2016) 21
Figure 2015 Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers 22
Figure 2016 Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers 22
Table Global Market Veterinary Vaccine Adjuvants Average Price (USD/Kg) of Key Manufacturers (2015 and 2016) 23
Figure Global Market Veterinary Vaccine Adjuvants Average Price of Key Manufacturers in 2015 24
Figure Global Market Veterinary Vaccine Adjuvants Average Price of Key Manufacturers in 2016 25
Table Manufacturers Veterinary Vaccine Adjuvants Headquarters and Key Sales Area 25
Table Global Veterinary Vaccine Adjuvants Production (MT) by Regions (2011-2016) 26
Figure 2015 Global Veterinary Vaccine Adjuvants Production Market Share by Regions 26
Figure 2016 Global Veterinary Vaccine Adjuvants Production Market Share by Regions 27
Table Global Veterinary Vaccine Adjuvants Revenue (M USD) by Regions (2011-2016) 27
Figure 2015 Global Veterinary Vaccine Adjuvants Revenue Market Share by Regions 28
Figure 2016 Global Veterinary Vaccine Adjuvants Revenue Market Share by Regions 28
Table Global Veterinary Vaccine Adjuvants Production (MT) by Types (2011-2016) 29
Table Global Veterinary Vaccine Adjuvants Production Share by Types (2011-2016) 29
Figure Production Market Share of Veterinary Vaccine Adjuvants by Types (2011-2016) 30
Figure 2015 Production Market Share of Veterinary Vaccine Adjuvants by Types 30
Figure 2016 Production Market Share of Veterinary Vaccine Adjuvants by Types 31
Table Global Veterinary Vaccine Adjuvants Revenue (M USD) by Types (2011-2016) 31
Table Global Veterinary Vaccine Adjuvants Revenue Share by Types (2011-2016) 31
Figure Production Revenue Share of Veterinary Vaccine Adjuvants by Types (2011-2016) 32
Figure 2015 Revenue Market Share of Veterinary Vaccine Adjuvants by Types 32
Figure 2016 Revenue Market Share of Veterinary Vaccine Adjuvants by Types 33
Table Global Veterinary Vaccine Adjuvants Price (USD/Kg) by Types (2011-2016) 33
Figure Global Veterinary Vaccine Adjuvants Production Growth by Type (2011-2016) 34
Table Global Veterinary Vaccine Adjuvants Consumption by Applications (2011-2016) 34
Figure Global Veterinary Vaccine Adjuvants Consumption Market Share by Applications in 2016 35
Table Global Veterinary Vaccine Adjuvants Consumption Growth Rate by Applications (2011-2016) 35
Figure Global Veterinary Vaccine Adjuvants Consumption Growth Rate by Applications (2011-2016) 36
Table SEPPIC Company Profile 37
Figure Vaccine Adjuvants Product Information of SEPPIC 38
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of SEPPIC 2015-2016 38
Table SDA BIO Company Profile 39
Figure Vaccine Adjuvants Product Information of SDA BIO 40
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of SDA BIO 2011-2016 40
Table Brenntag Biosector Company Profile 41
Figure Vaccine Adjuvants Product Information of Brenntag Biosector 42
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Brenntag Biosector 2015-2016 42
Table SPI Pharma Company Profile 43
Figure Vaccine Adjuvants Product Information of SPI Pharma 44
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of SPI Pharma 2015-2016 44
Table MVP Laboratories Company Profile 45
Figure Vaccine Adjuvants Product Information of MVP Laboratories 46
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of MVP Laboratories 2015-2016 46
Table Tj Kaiwei Company Profile 47
Figure Vaccine Adjuvants Product Information of Tj Kaiwei 48
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Tj Kaiwei 2015-2016 48
Table Novavax Company Profile 49
Figure Vaccine Adjuvants Product Information of Novavax 50
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Novavax 2015-2016 50
Table Zhuoyue Company Profile 51
Figure Vaccine Adjuvants Product Information of Zhuoyue 52
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Zhuoyue 2015-2016 52
Table Aphios Company Profile 53
Figure Vaccine Adjuvants Product Information of Aphios 54
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Aphios 2015-2016 54
Table Global Human Vaccine Adjuvants Production (MT) of Key Manufacturers (2015 and 2016) 55
Table Global Human Vaccine Adjuvants Production Share by Manufacturers (2015 and 2016) 55
Figure 2015 Human Vaccine Adjuvants Production Share by Manufacturers 56
Figure 2016 Human Vaccine Adjuvants Production Share by Manufacturers 56
Table Global Human Vaccine Adjuvants Revenue (M USD) by Manufacturers (2015 and 2016) 57
Table Global Human Vaccine Adjuvants Revenue Share by Manufacturers (2015 and 2016) 57
Figure 2015 Global Human Vaccine Adjuvants Revenue Share by Manufacturers 58
Figure 2016 Global Human Vaccine Adjuvants Revenue Share by Manufacturers 58
Table Global Market Human Vaccine Adjuvants Average Price (USD/Kg) of Key Manufacturers (2015 and 2016) 59
Figure Global Market Human Vaccine Adjuvants Average Price of Key Manufacturers in 2016 59
Table Manufacturers Human Vaccine Adjuvants Headquarters and Key Sales Area 60
Table Global Human Vaccine Adjuvants Production (MT) by Regions (2011-2016) 60
Figure 2015 Global Human Vaccine Adjuvants Production Market Share by Regions 61
Figure 2016 Global Human Vaccine Adjuvants Production Market Share by Regions 61
Table Global Human Vaccine Adjuvants Revenue (M USD) by Regions (2011-2016) 62
Figure 2015 Global Human Vaccine Adjuvants Revenue Market Share by Regions 62
Figure 2016 Global Human Vaccine Adjuvants Revenue Market Share by Regions 63
Table Global Human Vaccine Adjuvants Production (MT) by Types (2011-2016) 63
Table Global Human Vaccine Adjuvants Production Share by Types (2011-2016) 64
Figure Production Market Share of Human Vaccine Adjuvants by Types (2011-2016) 64
Figure 2016 Production Market Share of Human Vaccine Adjuvants by Types 65
Table Global Human Vaccine Adjuvants Revenue (M USD) by Types (2011-2016) 65
Table Global Human Vaccine Adjuvants Revenue Share by Types (2011-2016) 65
Figure Production Revenue Share of Human Vaccine Adjuvants by Types (2011-2016) 66
Figure 2016 Revenue Market Share of Human Vaccine Adjuvants by Types 66
Table Global Human Vaccine Adjuvants Price (USD/Kg) by Types (2011-2016) 67
Figure Global Human Vaccine Adjuvants Production Growth by Type (2011-2016) 67
Table Global Human Vaccine Adjuvants Consumption (MT) by Applications (2011-2016) 68
Figure Global Human Vaccine Adjuvants Consumption Market Share by Applications in 2015 68
Figure Global Human Vaccine Adjuvants Consumption Market Share by Applications in 2016 69
Table Global Human Vaccine Adjuvants Consumption Growth Rate by Applications (2011-2016) 69
Figure Global Human Vaccine Adjuvants Consumption Growth Rate by Applications (2011-2016) 70
Table GSK Company Profile 71
Figure Vaccine Adjuvants Product Information of GSK 72
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of GSK 2015-2016 72
Table CSL Limited Company Profile 73
Figure Vaccine Adjuvants Product Information of CSL Limited 74
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of CSL Limited 2015-2016 74
Table Brenntag Biosector Company Profile 75
Figure Vaccine Adjuvants Product Information of Brenntag Biosector 76
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Brenntag Biosector 2015-2016 76
Table SEPPIC Company Profile 77
Figure Vaccine Adjuvants Product Information of SEPPIC 78
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of SEPPIC 2015-2016 78
Table SPI Pharma Company Profile 79
Figure Vaccine Adjuvants Product Information of SPI Pharma 80
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of SPI Pharma 2015-2016 80
Table Novavax Company Profile 81
Figure Vaccine Adjuvants Product Information of Novavax 82
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Novavax 2015-2016 82
Table Avanti Polar Lipids Company Profile 83
Table Vaccine Adjuvants Product Information of Avanti Polar Lipids 84
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Avanti Polar Lipids 2015-2016 85
Table Aphios Company Profile 85
Figure Vaccine Adjuvants Product Information of Aphios 86
Table Vaccine Adjuvants Production (MT), Price (USD/Kg), Cost (USD/Kg), Gross (USD/Kg), Revenue (M USD) and Gross Margin of Aphios 2015-2016 87
Table Production Base and Market Concentration Rate of Raw Material 88
Table Key Suppliers of Raw Materials 88
Figure Manufacturing Cost Structure of Vaccine Adjuvants 90
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour) 91
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 91
Figure Cost of Employing a Factory Worker 93
Figure 2015 Estimated Labor Costs for the Whole Economy in EuropeR 94
Figure Monthly Minimum Wages in Asia 2016 95
Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year) 96
Figure Japan Overview of Average Monthly Wages 2015-2016 (JPY Thousand/Month) 96
Table Average Price of Electricity to Ultimate Customers 97
Figure Electricity Prices for Household Consumers in 2015 99
Figure Summary of the Driving Assumptions 100
Figure Industrial Electric Rates 2015 (PER KWH) 101
Figure Manufacturing Process Analysis of Vaccine Adjuvants 102
Figure Vaccine Adjuvants Industrial Chain Analysis 103
Table Major Buyers of Vaccine Adjuvants 104
Table Distributors/Traders List 107
Figure Global GDP Growth Rate for 2015 111
Figure US GDP 2006-2016 (Billion USD) 112
Figure US CPI Change 2016-2017 112
Figure EU GDP 2006-2016 (Billion USD) 113
Figure EU CPI Change 2012-2016 113
Figure Germany GDP 2006-2016 (Billion USD) 114
Figure Germany CPI Change 2016-2017 114
Figure UK GDP 2006-2016 (Billion USD) 114
Figure UK CPI Change 2016-2017 115
Figure Italy GDP 2006-2016 (Billion USD) 115
Figure Italy CPI Change 2016-2017 116
Figure Japan GDP 2006-2016 (Billion USD) 116
Figure Japan CPI Change 2012-2016 117
Figure China GDP 2006-2016 (Billion USD) 117
Figure China CPI Change 2016-2017 118
Figure Global Veterinary Vaccine Adjuvants Production and Growth Rate Forecast (2017-2022) 119
Figure Global Veterinary Vaccine Adjuvants Revenue and Growth Rate Forecast (2017-2022) 120
Table Global Veterinary Vaccine Adjuvants Production Forecast by Regions (2017-2022) 120
Table Global Veterinary Vaccine Adjuvants Production Forecast by Type (2017-2022) 121
Table Global Veterinary Vaccine Adjuvants Consumption Forecast by Application (2017-2022) 121
Table Veterinary Vaccine Adjuvants Price (USD/Kg) Forecast by Type (2017-2022) 121
Figure Global Human Vaccine Adjuvants Production and Growth Rate Forecast (2017-2022) 122
Figure Global Human Vaccine Adjuvants Revenue and Growth Rate Forecast (2017-2022) 123
Table Global Human Vaccine Adjuvants Production (MT) Forecast by Regions (2017-2022) 123
Table Global Human Vaccine Adjuvants Production Forecast by Type (2017-2022) 124
Table Global Human Vaccine Adjuvants Consumption Forecast by Application (2017-2022) 124
Table Human Vaccine Adjuvants Price (USD/Kg) Forecast by Type (2017-2022) 124
For Veterinary Vaccine Adjuvants 125
Human Vaccine Adjuvants 125